Bionano Genomics, Inc.
BNGO
•Stock Analysis$1.90
+0.00 (+0.00%)• Live
Bionano Genomics, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Bionano Genomics, Inc.
Key Financial Metrics
for Bionano Genomics, Inc.
P/E Ratio
-0.12
Revenue Growth
-14.79%
EPS Growth
+85.30%
Market Cap
$0.01B
Dividend Yield
0.00%
Debt/Equity
0.38
ROIC
-121.64%
FCF Yield
-353.41%
View additional metrics
Valuation
P/B Ratio0.21
EV/Sales0.95
Financial Health
Current Ratio1.70
Return on Assets-119.48%
Analyst Recommendations
for Bionano Genomics, Inc.
7 analysts
Consensus: Buy
About
for Bionano Genomics, Inc.
Company Details
for Bionano Genomics, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Robert Erik Holmlin
Employees
98
Market Cap
6.39M
Exchange
NASDAQ Capital Market
IPO Date
August 21, 2018
Website
www.bionanogenomics.comCIK
0001411690
ISIN
US09075F4046
CUSIP
09075F404
Country
US
Balance Sheet
for Bionano Genomics, Inc.
Cash Flow Statement
for Bionano Genomics, Inc.
Income Statement
for Bionano Genomics, Inc.
News
No news available at the moment.